Cargando…
Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212853/ https://www.ncbi.nlm.nih.gov/pubmed/35757084 http://dx.doi.org/10.1016/j.vacun.2022.06.001 |
| _version_ | 1784730701293158400 |
|---|---|
| author | Keikha, Masoud |
| author_facet | Keikha, Masoud |
| author_sort | Keikha, Masoud |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9212853 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92128532022-06-22 Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? Keikha, Masoud Vacunas Letter to the Editor Elsevier España, S.L.U. 2022 2022-06-17 /pmc/articles/PMC9212853/ /pubmed/35757084 http://dx.doi.org/10.1016/j.vacun.2022.06.001 Text en © 2022 Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Keikha, Masoud Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? |
| title | Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? |
| title_full | Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? |
| title_fullStr | Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? |
| title_full_unstemmed | Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? |
| title_short | Recommendation of a fourth SARS-CoV-2 vaccine dosage in vulnerable individuals, yes or not? |
| title_sort | recommendation of a fourth sars-cov-2 vaccine dosage in vulnerable individuals, yes or not? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212853/ https://www.ncbi.nlm.nih.gov/pubmed/35757084 http://dx.doi.org/10.1016/j.vacun.2022.06.001 |
| work_keys_str_mv | AT keikhamasoud recommendationofafourthsarscov2vaccinedosageinvulnerableindividualsyesornot |